BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors.
Reisländer T, Lombardi EP, Groelly FJ, Miar A, Porru M, Di Vito S, Wright B, Lockstone H, Biroccio A, Harris A, Londoño-Vallejo A, Tarsounas M.
Reisländer T, et al.
Nat Commun. 2019 Jul 17;10(1):3143. doi: 10.1038/s41467-019-11048-5.
Nat Commun. 2019.
PMID: 31316060
Free PMC article.